Connected healthcare services, or e-health services, are uniquely placed to offer patients comprehensive care from prevention to treatment to follow-up. For this reason, we are developing – alone and in partnership – e-health solutions and innovative digital tools to benefit and support patients, doctors, and healthcare professionals.
In late 2016, the Group launched its e-health division, WeHealth™ Digital Medicine. Its vocation? To improve the daily lives of patients and professionals through digital technology. The proposed digital solutions facilitate data collection, accurate diagnosis, therapeutic monitoring, prevention, and even prediction. Embracing a spirit of open innovation, WeHealth™ Digital Medicine identifies promising start-ups in digital health to co-develop solutions in the Group’s therapeutic areas.
By partnering with WeHealth™ Digital Medicine, start-ups enjoy the expertise of a multidisciplinary team to accelerate the development, industrialization, and distribution of their innovations in order to make them accessible to as many people as possible.WE HEALTH™ DIGITAL MEDICINE
We are developing tools, software, and apps for patients, doctors, and healthcare professionals that can be used throughout the course of care. In particular, we want to contribute to new uses and ensure the responsible processing of data collected. The availability of these solutions will differ from country to country.
Servier has partnered with GAIA, a global pioneer in digital therapies, to market Deprexis®, an online-based cognitive-behavioural therapy solution. This medical advance provides tailored therapeutic support to people with depression.
Although depression is a widespread disease, affecting nearly 350 million people worldwide (source, WHO), many patients are not getting the appropriate treatment they need. With advances like Deprexis®, more people can benefit from individualized therapeutic solutions.